Chongqing Huafang Wuling Mountain Pharmaceutical Co., Ltd.

Company Profile:
Chongqing Huafang Wuling Mountain Pharmaceutical Co., Ltd. (referred to as Huawu Pharmaceutical) is a wholly-owned subsidiary of the Huafang Pharmaceutical division under the Holley Group. It is located at No. 108 Jinyuan Avenue, Banxi Light Industry Park, Youyang Tujia and Miao Autonomous County, Chongqing.
The company covers an area of 251 mu, with fixed assets of 150 million yuan and more than 160 production and technical personnel. The company has multiple products including artemisinin, artemether, dihydroartemisinin, artesunate, Maqin cough syrup, tannin protein, tannin protein tablets, etc. Its designed production capacity is an annual output of 40 tons of artemisinin, 35 tons of artemisinin derivatives, and 3 million bottles of syrup. The turmeric saponin production line, which is about to be put into operation, has a capacity of 300 tons. It is currently the earliest and largest artemisinin API production base in China with the most complete variety.
Huawu Pharmaceutical actively pursues new leaps in management and technical operations. Taking the opportunity of passing the new version of GMP certification by the National Medical Products Administration, it is comprehensively improving the company's overall quality, striving to develop into a high-tech antimalarial industry using artemisinin as raw material. Huawu Pharmaceutical was once the first enterprise in the artemisinin production field to pass national GMP certification. Its production quality control system has been recognized and affirmed by the World Health Organization, and all products are exported.